LENZ Therapeutics LENZ
NASDAQ LENZ
$3.22 +0.03 (+0.94%)
As of: Oct 21, 2026 · 3:59 PM EDT

LENZ Therapeutics (LENZ) Change in Receivables (2026)

Updated

LENZ Therapeutics' Change in Receivables was $99,000 in Q2 2026, up 607.1% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Change in Receivables (2026) Analysis & Trends

On a trailing twelve-month basis, LENZ Therapeutics' Change in Receivables was $113,000 through Jun 30, 2026; for FY2025, it was $329,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 LENZ Therapeutics 101.65 Mn -871.25 Mn 5.21 Mn 99,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 99,000.00
Mar 31, 2026 14,000.00
API Access

LENZ Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=LENZ&period=max&api_key=YOUR_API_KEY